CAR-T cell infusion
PG-004-3
Phase 1 small_molecule active
Quick answer
CAR-T cell infusion for Hematolymphoid Malignancies is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Hematolymphoid Malignancies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active